policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
AVMA news
Gene therapy may soon help treat mitral valve disease
Phibro Animal Health and Rejuvenate Bio are developing an expected gene therapy for canine mitral valve disease.
JAVMA news
In Short
Specialties proposed, ranitidine drugs contaminated, national disease list drafted
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
AVMA news
Until more science is available, FDA will end public updates on potential link between certain diets and canine dilated cardiomyopathy
The Food and Drug Administration plans to end routine updates on the investigation of case reports of nonhereditary canine dilated cardiomyopathy and…
JAVMA news
In Short
Aquarium cleaner death, anxiety in dogs, and more in the May 1 “In Short” section